Arcus Biosciences, Inc. Comprehensive Income
Arcus Biosciences, Inc. (RCUS) reported Comprehensive Income of -$91.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$91.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$129.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$106.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$135.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$353.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$283.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$300.00M.
- Arcus Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$273.00M, a 625.00% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$91.00M 10-Q · filed 2026-08-05 | -$220.00M 10-Q · filed 2026-08-05 | -$326.00M derived: sum of 3 quarters · filed 2026-08-05 | -$461.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$129.00M 10-Q · filed 2026-05-05 | -$235.00M derived: sum of 2 quarters · filed 2026-05-05 | -$370.00M derived: sum of 3 quarters · filed 2026-05-05 | -$370.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$241.00M derived: sum of 2 quarters · filed 2026-02-25 | -$241.00M derived: sum of 3 quarters · filed 2026-08-05 | -$353.00M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$135.00M 10-Q · filed 2025-10-28 | -$135.00M derived: sum of 2 quarters · filed 2026-08-05 | -$247.00M 10-Q · filed 2025-10-28 | -$342.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | -$112.00M 10-Q · filed 2026-08-05 | -$207.00M derived: sum of 3 quarters · filed 2026-08-05 | -$297.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$112.00M 10-Q · filed 2026-05-05 | -$207.00M derived: sum of 2 quarters · filed 2026-05-05 | -$297.00M derived: sum of 3 quarters · filed 2026-05-05 | -$390.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$185.00M derived: sum of 2 quarters · filed 2026-02-25 | -$278.00M derived: sum of 3 quarters · filed 2026-02-25 | -$283.00M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$90.00M 10-Q · filed 2025-10-28 | -$183.00M derived: sum of 2 quarters · filed 2025-10-28 | -$188.00M 10-Q · filed 2025-10-28 | -$266.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$93.00M 10-Q · filed 2025-08-06 | -$98.00M 10-Q · filed 2025-08-06 | -$176.00M derived: sum of 3 quarters · filed 2026-02-25 | -$246.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$5.00M 10-Q · filed 2025-05-06 | -$83.00M derived: sum of 2 quarters · filed 2026-02-25 | -$153.00M derived: sum of 3 quarters · filed 2026-02-25 | -$228.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$148.00M derived: sum of 2 quarters · filed 2026-02-25 | -$223.00M derived: sum of 3 quarters · filed 2026-02-25 | -$300.00M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$70.00M 10-Q · filed 2024-11-06 | -$145.00M derived: sum of 2 quarters · filed 2024-11-06 | -$222.00M 10-Q · filed 2024-11-06 | -$287.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$75.00M 10-Q · filed 2024-08-08 | -$152.00M 10-Q · filed 2024-08-08 | -$217.00M derived: sum of 3 quarters · filed 2025-02-25 | -$284.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | -$77.00M 10-Q · filed 2024-05-08 | -$142.00M derived: sum of 2 quarters · filed 2025-02-25 | -$209.00M derived: sum of 3 quarters · filed 2025-02-25 | -$278.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$132.00M derived: sum of 2 quarters · filed 2025-02-25 | -$201.00M derived: sum of 3 quarters · filed 2025-02-25 | -$273.00M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$67.00M 10-Q · filed 2023-11-07 | -$67.48M 10-Q · filed 2022-11-02 | -$136.00M derived: sum of 2 quarters · filed 2023-11-07 | -$208.00M 10-Q · filed 2023-11-07 | -$208.08M 10-Q · filed 2022-11-02 | $70.67M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2022-06-30 | -$69.00M 10-Q · filed 2023-08-07 | -$69.22M 10-Q · filed 2022-08-03 | -$141.00M 10-Q · filed 2023-08-07 | -$140.61M 10-Q · filed 2022-08-03 | $137.67M derived: sum of 3 quarters · filed 2024-02-21 | $59.65M derived: sum of 4 quarters · filed 2024-02-21 | ||
| 2022-03-31 | -$72.00M 10-Q · filed 2023-05-09 | -$71.39M 10-Q · filed 2022-05-09 | $206.67M derived: sum of 2 quarters · filed 2024-02-21 | $128.65M derived: sum of 3 quarters · filed 2024-02-21 | $52.64M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $278.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $200.65M derived: sum of 2 quarters · filed 2024-02-21 | $124.64M derived: sum of 3 quarters · filed 2024-02-21 | $52.00M 10-K · filed 2024-02-21 | $51.52M 10-K · filed 2022-02-23 | |||
| 2021-09-30 | -$78.02M 10-Q · filed 2022-11-02 | -$154.03M derived: sum of 2 quarters · filed 2022-11-02 | -$226.67M 10-Q · filed 2022-11-02 | -$278.69M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$76.01M 10-Q · filed 2022-08-03 | -$148.65M 10-Q · filed 2022-08-03 | -$200.66M derived: sum of 3 quarters · filed 2023-02-28 | -$198.91M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$72.64M 10-Q · filed 2022-05-09 | -$124.65M derived: sum of 2 quarters · filed 2023-02-28 | -$122.89M derived: sum of 3 quarters · filed 2023-02-28 | -$168.11M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$52.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$50.25M derived: sum of 2 quarters · filed 2023-02-28 | -$95.47M derived: sum of 3 quarters · filed 2023-02-28 | -$123.00M 10-K · filed 2023-02-28 | -$122.88M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $1.76M 10-Q · filed 2021-11-08 | -$43.46M derived: sum of 2 quarters · filed 2021-11-08 | -$70.99M 10-Q · filed 2021-11-08 | -$87.58M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$45.22M 10-Q · filed 2021-08-05 | -$72.75M 10-Q · filed 2021-08-05 | -$89.33M derived: sum of 3 quarters · filed 2022-02-23 | -$111.75M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | -$27.53M 10-Q · filed 2021-05-05 | -$44.12M derived: sum of 2 quarters · filed 2022-02-23 | -$66.53M derived: sum of 3 quarters · filed 2022-02-23 | -$94.53M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | -$16.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$39.00M derived: sum of 2 quarters · filed 2022-02-23 | -$67.00M derived: sum of 3 quarters · filed 2022-02-23 | -$84.54M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$22.41M 10-Q · filed 2020-11-05 | -$50.42M derived: sum of 2 quarters · filed 2020-11-05 | -$67.95M 10-Q · filed 2020-11-05 | -$80.25M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$28.01M 10-Q · filed 2020-08-06 | -$45.54M 10-Q · filed 2020-08-06 | -$57.83M derived: sum of 3 quarters · filed 2021-02-25 | -$68.67M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$17.53M 10-Q · filed 2020-05-05 | -$29.83M derived: sum of 2 quarters · filed 2021-02-25 | -$40.66M derived: sum of 3 quarters · filed 2021-02-25 | -$54.18M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$12.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$23.13M derived: sum of 2 quarters · filed 2021-02-25 | -$36.65M derived: sum of 3 quarters · filed 2021-02-25 | -$49.66M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$10.84M 10-Q · filed 2019-11-05 | -$24.36M derived: sum of 2 quarters · filed 2019-11-05 | -$37.37M 10-Q · filed 2019-11-05 | -$50.61M derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | -$13.52M 10-Q · filed 2019-08-06 | -$26.53M 10-Q · filed 2019-08-06 | -$39.77M derived: sum of 3 quarters · filed 2019-08-06 | -$62.88M derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | -$13.01M 10-Q · filed 2019-05-02 | -$26.25M derived: sum of 2 quarters · filed 2019-05-02 | -$49.36M derived: sum of 3 quarters · filed 2019-05-02 | -$58.90M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | -$13.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | -$36.35M derived: sum of 2 quarters · filed 2019-03-05 | -$45.89M derived: sum of 3 quarters · filed 2019-03-05 | -$53.10M 10-K · filed 2019-03-05 | ||||
| 2017-09-30 | -$23.11M 10-Q · filed 2018-11-08 | -$32.65M derived: sum of 2 quarters · filed 2018-11-08 | -$39.85M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$9.54M 10-Q · filed 2018-08-06 | -$16.75M 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | -$7.21M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | -$18.00M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |